Oncology MRI

Leveraging AI technology, the AiMIFY software reportedly facilitates double the contrast enhancement in comparison to gadolinium-based contrast agents (GBCAs) for brain MRI.

For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.

Catch up on the top radiology content of the past week.

Noting a rapidly changing paradigm for the treatment of rectal cancers, the authors of a new literature review discuss current and emerging principles in MRI assessment and staging.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in September 2024.

The addition of parameters such as patient age, MIP sign and associated imaging features to the Kaiser score demonstrated a 95.6 percent AUC for breast cancer detection of enhancing lesions on breast MRI in recently published research.

Catch up on the most-well viewed prostate imaging content in September 2024.

Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.

Catch up on the top radiology content of the past week.

In a study involving 396 confirmed neuroendocrine tumor liver metastases, researchers found that Gd-EOB-DTPA-enhanced MRI offered 19 percent higher sensitivity than polyenergetic CT.

In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.

Catch up on the most-well viewed radiology content in August 2024.

Catch up on the top AI-related news and research in radiology over the past month.

A new MRI contrast agent may provide a viable non-invasive alternative for the detection of interstitial cystitis, according to preliminary research presented at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan.

Based on surveys of neuro-oncologists taken before and after the use of MRI perfusion imaging and spectroscopy in patients with high-grade gliomas, researchers found the advanced imaging would have led to a greater than fivefold change in patient management in comparison to previous research.

Catch up on the top radiology content of the past week.

External validation testing revealed a deep learning combination of breast MRI, ultrasound and clinical factors had a 10 percent higher AUC for predicting axillary lymph node metastasis than sole use of MRI- or ultrasound-based deep learning models in patients with breast cancer.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.

Catch up on the top radiology content of the past week.

While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.

The deep learning SubtleSynth software creates synthetic STIR images that are reportedly interchangeable with conventional sequences obtained from T1 and T2-weighted MRI.

The Aperto Lucent open 0.4T MRI platform reportedly offers enhanced fat suppression and spatial resolution capabilities in addition to its open architecture design.